News & Updates
Filter by Specialty:

Camostat mesylate flops against SARS-CoV-2
12 Jul 2022
The serine protease inhibitor camostat mesylate does not appear to be an effective antiviral agent in patients with early-phase COVID-19, having failed to stop SARS-CoV-2 in its tracks in a phase II trial.